Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Operating Profit

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Operating Profit (Excl OI) ₹240 Cr₹1,547 Cr₹128 Cr₹128 Cr

What is the latest Operating Profit of CORONA REMEDIES ?

The latest Operating Profit ratio of CORONA REMEDIES is ₹240 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹240 Cr
Mar2025₹1,547 Cr
Mar2024₹128 Cr
Mar2023₹128 Cr

How is Operating Profit of CORONA REMEDIES Trending?

Years Operating Profit % Change
Mar2026 ₹240 Cr
-84.49
Mar2025 ₹1,547 Cr
1,109.05
Mar2024 ₹128 Cr
0.00
Mar2023 ₹128 Cr -

Compare Operating Profit of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹11,714.0 Cr 5.7% 8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,148.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹179,009.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,779.0 Cr -0.2% -0.3% 35% Stock Analytics
CIPLA ₹115,772.0 Cr 3.1% 1% -11.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,616.0 Cr 1.1% -2.1% -5.6% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

5.7%

8%

NA
SENSEX

-0.8%

1.4%

-6.8%


You may also like the below Video Courses